1. Scrip
  2. >>Therapy Areas
  3. >>Alimentary/Metabolic

Ipca gets first approval for HCQ in diabetes

 
• By Anju Ghangurde

India has approved the use of hydroxychloroquine (HCQ) in Type 2 diabetes - potentially the first such clearance for the product.

India has approved the use of hydroxychloroquine (HCQ) in Type 2 diabetes - potentially the first such clearance for the product.

Innovator Sanofi's Plaquenil (hydroxychloroquine sulfate) is currently indicated for the treatment of rheumatoid arthritis, lupus disease and malaria, though Plaquenil...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Alimentary/Metabolic

More from Therapy Areas

ProKidney Pins Hopes On Accelerated Approval For Rilparencel

 
• By Alaric DeArment

After posting encouraging Phase II results, the company plans to meet with the US FDA about using data from an ongoing Phase III study for an accelerated approval.

Merck & Co.’s Verona Acquisition Marks A Return To Respiratory

 
• By Jessica Merrill

With the $10bn acquisition of Verona, Merck gains the marketed COPD drug Ohtuvayre, reentering respiratory, where it was once a leader with Singulair.

Lilly’s Kisunla Label Update Lowers ARIA-E Risk For Alzheimer’s Patients

 
• By Mandy Jackson

The updated US FDA label modifies dose titration based on TRAILBLAZER-ALZ 6, a study that showed a more gradual rise in dosing levels reduced ARIA-E incidence without reducing amyloid clearance.